L. Citti and G. Rainaldi Pages 11 - 24 ( 14 )
Ribozymes are RNA molecules that have the ability to catalyse the cleavage and formation of covalent bonds in RNA strands at specific sites. The “hammerhead” motif, approximately 30-nucleotide long, is the smallest endonucleolytic cis-acting ribozyme structure found in natural circular RNAs of some plant viroids. Hammerhead ribozymes became appealing when it was shown that it is possible to produce trans-acting ribozymes directed against RNA sequences of interest. Since then, gene-tailored ribozymes have been designed, produced and given to cells to knock down the expression of specific genes. At present, this technology has advanced so much that many hammerhead ribozymes are being used in clinical trials. With this work we would provide some guidelines to design efficient trans-acting hammerhead ribozymes as well as review the recent results obtained with them as gene therapy tools.
hammerhead ribozymes, gene knockdown, gene therapy, gene drugs, synthetic oligonucleotides
Laboratorio di Terapia Genica e Molecolare, Istituto di Fisiologia Clinica del CNR, Area della Ricerca, ViaG. Moruzzi, 1, 56124 Pisa, Italy.